plasma-lyte 148 (approx. ph 7.4) 1000ml injection bag ahb2544
baxter healthcare pty ltd - sodium acetate, quantity: 3.68 g/l; potassium chloride, quantity: 370 mg/l; magnesium chloride hexahydrate, quantity: 300 mg/l; sodium gluconate, quantity: 5.02 g/l; sodium chloride, quantity: 5.26 g/l - injection, intravenous infusion - excipient ingredients: sodium hydroxide; water for injections - plasma-lyte 148 (approx. ph 7.4) iv infusion is indicated as a source of water and electrolytes or as an alkalinising agent.
plasma-lyte 148 (approx. ph 7.4) 500ml injection bag ahb2543
baxter healthcare pty ltd - sodium gluconate, quantity: 5.02 g/l; sodium acetate, quantity: 3.68 g/l; sodium chloride, quantity: 5.26 g/l; magnesium chloride hexahydrate, quantity: 300 mg/l; potassium chloride, quantity: 370 mg/l - injection, intravenous infusion - excipient ingredients: sodium hydroxide; water for injections - plasma-lyte 148 (approx. ph 7.4) iv infusion is indicated as a source of water and electrolytes or as an alkalinising agent.
plasma-lyte® 148 (ph 7.4) solution for infusion
baxter holding b.v. - sodium chloride; potassium chloride; magnesium chloride hexahydrate; sodium acetate trihydrate ; sodium gluconate - solution for infusion - 148 (ph 7.4) - solutions affecting the electrolyte balance; electrolytes
veltassa
vifor fresenius medical care renal pharma france - patiromer sorbitex calcium - hyperkalemia - drugs for treatment of hyperkalemia and hyperphosphatemia - veltassa is indicated for the treatment of hyperkalaemia in adults.
ph 12 sterile diluent for flolan liquid
glaxosmithkline inc - glycine; sodium chloride; water - liquid - 94mg; 73.3mg; 50ml - glycine 94mg; sodium chloride 73.3mg; water 50ml - diluents
lokelma
astrazeneca ab - sodium zirconium cyclosilicate - hyperkalemia - all other therapeutic products - lokelma is indicated for the treatment of hyperkalaemia in adult patients.
amcil-a v. inj
perk ph. - amikacin - inj - 100/250;mg - v.
amcil-a v. inj
perk ph. - amikacin - inj - 500mg - v.
amcil-t v. ds inj
perk ph. - cefotaxime - ds inj - 1gm - v.
amcil-t v. inj
perk ph. - cefotaxime - inj - 250/500;mg - v.